Related Experiment Video
Updated: Feb 2, 2026

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
Published on: January 12, 2024
Flow cytometry immunophenotyping of vitreous specimens does not contribute to diagnosis of lymphoma without
Colby A Cantu1, Cynthia L Green2, Thomas J Cummings1
1Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Insights
Diagnostic vitrectomy with flow cytometry immunophenotyping (FCI) is valuable for detecting intraocular lymphoma. Absence of large lymphocytes on cytology predicts negative FCI results, suggesting FCI may not be needed in such cases.
Area of Science:
- Ophthalmology
- Hematology
- Cytopathology
Background:
- Diagnostic vitrectomy with flow cytometry immunophenotyping (FCI) is increasingly utilized for challenging cases.
- Evaluating the combined utility of cytopathology and FCI in pars plana vitrectomy is crucial.
- Identifying cytologic predictors of FCI outcomes can refine diagnostic indications.
Purpose of the Study:
- To assess the diagnostic value of combined cytopathology and FCI in pars plana vitrectomy.
- To identify cytologic features that predict flow cytometry immunophenotyping outcomes.
- To establish clearer indications for using FCI in diagnostic vitrectomy.
Main Methods:
- Retrospective analysis of 99 diagnostic pars plana vitrectomy specimens (2010-2016).
- Evaluation of associations between cytologic features and FCI results.
- Statistical analysis of cytologic findings and FCI outcomes.
Main Results:
- Cytopathology evaluation was diagnostic in 39.4% of specimens.
- FCI performed on 90.4% of lymphoma-indicated specimens showed abnormal lymphocytes in 13.6%.
- Absence of large lymphocytes was the sole significant predictor of negative FCI (NPV=97.7%, OR=14.0, P=0.034).
Conclusions:
- Diagnostic vitrectomy with cytopathology is valuable for intraocular lymphoma diagnosis.
- Concomitant FCI is useful for confirming intraocular lymphoma.
- Absence of large lymphocytes predicts negative FCI, potentially obviating its use.
Background:
Diagnostic vitrectomy with flow cytometry immunophenotyping (FCI) is being increasingly used as part of screening for diagnostically challenging cases. We aim to evaluate the utility of combined cytopathology and FCI in diagnostic pars plana vitrectomy. We also aim to evaluate cytologic features that could potentially predict FCI outcomes. This study provides clearer indications for use of FCI in diagnostic vitrectomy.
Methods:
A case series of diagnostic pars plana vitrectomy specimens from 2010 to 2016 from a single institution was retrospectively evaluated. Associations between cytologic features and FCI were analyzed statistically.
Results:
Ninety-nine vitrectomy specimens (90 patients) were evaluated. Evaluation was diagnostic in 39 of 99 (39.4%) specimens. FCI was performed in 66 of 73 (90.4%) specimens collected for lymphoma indication, and 9 of those 66 FCIs (13.6%) demonstrated abnormal lymphocytes. FCI was performed in 10 of 26 (38.5%) specimens collected for non-lymphomatous indications; all 10 FCIs failed to demonstrate lymphocyte abnormality. The absence of large lymphocytes frequently demonstrated negative FCI (negative predictive value = 97.7%), and was the sole cytologic feature significantly associated with a negative FCI result [OR, 14.0; 95% CI, 1.65-635.6; P = .034].
Conclusions:
Diagnostic vitrectomy with cytopathology evaluation is valuable, and concomitant FCI is useful to confirm intraocular lymphoma. However, the absence of large lymphocytes on cytologic examination is the single significant predictor of a negative FCI, and this finding should preclude the use of FCI.
More Related Videos
Related Concept Videos
Flow Cytometry
In...
Self-Help Support Groups
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Binet's Contribution to Measures of Intelligence
Gene Flow
Wechsler's Contribution to Measures of Intelligence
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...

